Introducing pharmacy students to pharmacogenomic analysis

American Journal of Pharmaceutical Education

Volumn 73, Issue 4, 2009, Pages

  Krynetskiy, Evgeny ^a   Calligaro, Ina Lee ^a  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

DNA; Instructional design; Pharmacogenomics

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE;

COMPREHENSION; CURRICULUM; DNA DETERMINATION; DNA EXTRACTION; EDUCATIONAL TECHNOLOGY; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HIGH THROUGHPUT SCREENING; LEARNING ENVIRONMENT; MEDICAL EDUCATION; PHARMACOGENOMICS; PHARMACY STUDENT; REVIEW; SALIVA; SINGLE NUCLEOTIDE POLYMORPHISM; STUDENT ATTITUDE; ARTICLE; COMPARATIVE STUDY; EDUCATION; GENETIC ASSOCIATION; GENETIC MARKER; GENETICS; HUMAN; METHODOLOGY; PHARMACOGENETICS;

EDUCATION, PHARMACY, GRADUATE; GENETIC MARKERS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; PHARMACOGENETICS; STUDENTS, PHARMACY;

EID: 67650507671     PISSN: 00029459     EISSN: 15536467     Source Type: Journal    
DOI: 10.5688/aj730471     Document Type: Review

References (16)

1. Gurwitz D, Lunshof JE, Dedoussis G, et al. Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education. Pharmacogen J. 2005;5(4):221-225 (Pubitemid 41131714)
2. Johnson JA, Bootman JL, Evans WE, et al. Pharmacogenomics: a scientific revolution in pharmaceutical sciences and pharmacy practice. Report of the 2001/02 Academic Affairs Committee. Am J Pharm Educ. 2002;66(4):12S-4S.
3. Core Competencies in Genetics Essential for all health-care professionals. January 2001. National Coalition for Health Professional Education in Genetics (NCHPEG) 2001. http://www. nchpeg.org/core/Core-Comps- English-2007.pdf
4. Accreditation Standards and Guidelines for the Professional Program in Pharmacy Leading to the Doctor of Pharmacy Degree. February 2006. Accreditation Council for Pharmacy Education; 2006. http://www.acpe-accredit.org/
5. Brock TP, Faulkner CM, Williams DM, Smith SR. Continuingeducation programs in pharmacogenomics for pharmacists. Am J Health-Syst Pharm. 2002;59(8):722-725
6. Latif D, McKay A. Pharmacogenetics and pharmacogenomics instruction in colleges and schools of pharmacy in the United States. Am J Pharm Educ. 2005;69(2):152-156 (Pubitemid 41569487)
7. Brazeau D, Brazeau GA. A required course in human genomics, pharmacogenomics, and bioinformatics. Am J Pharm Educ. 2006;70(6):1-6. (Pubitemid 44917060)
8. Hein DW, Doll MA, Rustan TD, Ferguson RJ. Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions. Cancer Res2E 1995;55(16):3531-3536
9. Daly AK. Pharmacogenetics of the major polymorphic metabolizing enzymes. Fundamentals Clin Pharmacol. 2003;17(1):27-41. (Pubitemid 36241451)
10. Krynetskiy E, McDonnell P. Building individualized medicine: prevention of adverse reactions to warfarin therapy. J Pharmacol Exp Ther. 2007;322(2):427-434
11. Genomics at FDA. Center for Drug Evaluation and Research. U.S. Food and Drug Administration. Available at: http://www.fda. gov/Drugs/ScienceResearch/ ResearchAreas/Pharmacogenetics/ ucm085427.htm. Accessed June 6, 2008.
12. Krynetskiy EY, Evans WE. Closing the gap between science and clinical practice: the thiopurine S-methyltransferase polymorphism moves forward. Pharmacogenetics. 2004;14(7):395-396 (Pubitemid 38971229)
13. Evans DAP, Manley KA, McKuisick VA. Genetic control of isoniazid acetylation in man. Br Med J. 1960;2(5197):485-491
14. Patin E, Barreiro LB, Sabeti PC, et al. Deciphering the ancient and complex evolutionary history of human arylamine Nacetyltransferase genes. Am J Hum Gen. 2006;78(3):423-436 (Pubitemid 43291225)
15. Cascorbi I, Brockmoller J, Mrozikiewicz PM, Muller A, Roots I. Arylamine N-acetyltransferase activity in man. Drug Metab Rev. 1999;31(2):489-502.
16. Hein DW, Doll MA, Fretland AJ, et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev. 2000;9(1):29-42. (Pubitemid 30062907)